<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/Newsletter/style.css"/>
<title>Three Stocks Estimated To Be Trading Below Intrinsic Value By Up To 34.7 Percent â€” Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/Newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">Three Stocks Estimated To Be Trading Below Intrinsic Value By Up To 34.7 Percent</h2>
    <div class="badge">2025-09-15T11:38:10+00:00</div>
    <ul>
      <li>The company recently became profitable, reporting a net income of US$35 million for Q2 2025.</li>
<li>Revenue growth is projected at 15.2% annually, outpacing the broader US market&#x27;s forecasted growth rate.</li>
<li>Estimated Discount To Fair Value: 24.9% Grab Holdings is trading at US$6, below its estimated fair value of US$7.99, suggesting potential undervaluation based on cash flows.</li>
<li>Top 10 Undervalued Stocks Based On Cash Flows In The United States | Name | Current Price | Fair Value (Est) | Discount (Est) | | Phibro Animal Health (PAHC) | $39.62 | $77.67 | 49% | | Peapack-Gladstone Financial (PGC)</li>
<li>However, its return on equity is expected to remain low at 9.6% in three years despite strong earnings growth projections of 37.5% annually.</li>
<li>Operations: The company&#x27;s revenue segments include Mobility at $1.13 billion, Deliveries at $1.64 billion, and Financial Services at $297 million.</li>
<li>Eli Lilly Overview: Eli Lilly and Company discovers, develops, and markets human pharmaceuticals globally, with a market cap of $678.14 billion.</li>
    </ul>
    <p>
      <a class="btn" href="https://x.com/intent/tweet?text=Three%20Stocks%20Estimated%20To%20Be%20Trading%20Below%20Intrinsic%20Value%20By%20Up%20To%2034.7%20Percent%0A%E2%80%A2%20The%20company%20recently%20became%20profitable%2C%20reporting%20a%20net%20income%20of%20US%2435%20million%20for%20Q2%202025.%0A%E2%80%A2%20Revenue%20growth%20is%20projected%20at%2015.2%25%20annually%2C%20outpacing%20the%20broader%20US%20market%27s%20forecasted%20growth%20rate.%0A%E2%80%A2%20Estimated%20Discount%20To%20Fair%20Value%3A%2024.9%25%20Grab%20Holdings%20is%20trading%20at%20US%246%2C%20below%20its%20estimated%20fair%20value%20of%20US%247.99%2C%20suggesting%20potential%20undervaluation%20based%20on%20cash%20flows.%0A%E2%80%A2%20Top%2010%20Undervalued%20Stocks%20Based%20On%20Cash%20Flows%20In%20The%20United%20States%20%7C%20Name%20%7C%20Current%20Price%20%7C%20Fair%20Value%20%28Est%29%20%7C%20Discount%20%28Est%29%20%7C%20%7C%20Phibro%20Animal%20Health%20%28PAHC%29%20%7C%20%2439.62%20%7C%20%2477.67%20%7C%2049%25%20%7C%20%7C%20Peapack-Gladstone%20Financial%20%28PGC%29%0A%E2%80%A2%20However%2C%20its%20return%20on%20equity%20is%20expected%20to%20remain%20low%20at%209.6%25%20in%20three%20years%20despite%20strong%20earnings%20growth%20projections%20of%2037.5%25%20annually.%0A%E2%80%A2%20Operations%3A%20The%20company%27s%20revenue%20segments%20include%20Mobility%20at%20%241.13%20billion%2C%20Deliveries%20at%20%241.64%20billion%2C%20and%20Financial%20Services%20at%20%24297%20million.%0A%E2%80%A2%20Eli%20Lilly%20Overview%3A%20Eli%20Lilly%20and%20Company%20discovers%2C%20develops%2C%20and%20markets%20human%20pharmaceuticals%20globally%2C%20with%20a%20market%20cap%20of%20%24678.14%20billion.&url=https%3A%2F%2Fsuavir600.github.io%2FNewsletter%2Farticles%2Fthree-stocks-estimated-to-be-trading-below-intrinsic-value-by-up-to-34-7-percent%2F" target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a class="btn" href="https://finance.yahoo.com/news/three-stocks-estimated-trading-below-113810824.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>